Corvus Pharmaceuticals Inc. – Indentures

NASDAQ: CRVS
Share price (7/2/26): $15.23
Market cap (7/2/26): $1.281 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Indentures Filter

from S-3ASR 52 pages Corvus Pharmaceuticals, Inc. Indenture Dated as of , 20___ [ ] Trustee

from 10-K 6 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from S-3 51 pages Corvus Pharmaceuticals, Inc. Indenture Dated as of , 20__ [ ], as Trustee

from 10-Q 4 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 8-K 16 pages Corvus Pharmaceuticals, Inc. [Form Of] Warrant to Purchase Shares of Common Stock or Pre-Funded Warrants

from 8-K 14 pages Corvus Pharmaceuticals, Inc. [Form Of] Warrant to Purchase Shares of Common Stock

from S-3 51 pages Corvus Pharmaceuticals, Inc. Indenture Dated as of , 20__ [ ], as Trustee

from 10-K 4 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-K 5 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 8-K 11 pages Form of Warrant to Purchase Common Stock Corvus Pharmaceuticals, Inc. Warrant to Purchase Common Stock

from S-1/A 56 pages Corvus Pharmaceuticals, Inc. Amended and Restated Investors’ Rights Agreement

from S-1 2 pages Indenture or similar